Withdrawal of a Registration Statement Withdrawal Request (rw Wd)
13 Junho 2019 - 5:37PM
Edgar (US Regulatory)
ContraVir Pharmaceuticals, Inc.
399 Thornall Street
Edison, NJ 08837
June 13, 2019
VIA EDGAR
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Dorrie Yale
Re:
ContraVir Pharmaceuticals, Inc. (the Registrant)
Form S-1, as amended
File No. 333-231604
Dear Ms. Yale:
Registrant hereby respectfully requests the withdrawal, effective immediately, of the registration withdrawal request filed on behalf of the Registrant on June 13, 2019 on Form RW (SEC Accession No. 0001104659-19-035316) (the Form RW) in respect of the above-referenced registration statement. The filing of the Form RW was made in error.
Please contact Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 if there are any questions with respect to this request.
|
Thank you,
|
|
|
|
CONTRAVIR PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
By:
|
/s/ Robert Foster
|
|
Name:
|
Robert Foster
|
|
Title:
|
Chief Executive Officer
|
Contravir Pharmaceuticals Inc (NASDAQ:CTRV)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Contravir Pharmaceuticals Inc (NASDAQ:CTRV)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Contravir Pharmaceuticals (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Contravir Pharmaceuticals, Inc.